Cancer Generics Expected to Reach US$ 19 Billion by 2017
Cancer, one of the leading causes of death worldwide is believed to affect 1 in 2 people by 2030. With such a formidable incidence and increasing life expectancy, Cancer Generics are destined for enormous growth.
View full press release